Table 4 Treatment outcome in the study cohort of 276 extra-pulmonary tuberculosis cases according to the WHO/EuroTB classification, modified for 'default' and 'physician's decision to stop early'
From: Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study
Treatment group | FAVOURABLE | UNFAVOURABLE¹ | On treatment at 12 months | Not known | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Cured | Treatment completed | Subtotal | Death | Transfer out | Default | Physician's decision to stop early | Subtotal | ||||
Standard treatment A | 15 10.7% | 82 58.6% | 97 69.3% | 18 12.9% | 0 0 | 3 2.1% | 14 10.0% | 35 25.0% | 7 5.0% | 1 0.7% | 140 100% |
Standard treatment B | 1 3.6% | 9 32.1% | 10 35.7% | 5 17.9% | 0 | 1 3.6% | 8 28.6% | 14 50.0% | 4 14.3% | 0 | 28 100% |
Standard treatment with short intensive phase C | 0 | 14 77.8% | 14 77.8% | 1 5.6% | 0 | 0 | 2 11.1% | 3 16.7% | 1 5.6% | 0 | 18 100% |
Standard treatment D | 3 10.0% | 10 33.3% | 13 43.3% | 1 3.3% | 0 | 1 3.3% | 4 13.3% | 6 20.0% | 11 36.7% | 0 | 30 100% |
Other combination of tuberculosis drugs | 3 8.3% | 16 44.4% | 19 52.7% | 6 16.7% | 1 2.8% | 5 13.9% | 3 8.3% | 15 41.7% | 1 2.8% | 1 2.8% | 36 100% |
Ineffective treatment | 0 | 4 80.0% | 4 80.0% | 1 20.0% | 0 | 0 | 0 | 1 20.0% | 0 | 0 | 5 100% |
Overall outcome with any treatment | 22 | 135 52.5% | 157 61.1% | 32 12.5% | 1 0.4% | 10 3.9% | 31 12.1% | 74 28.8% | 24 9.3% | 2 0.8% | 257 100% |
No treatment | NA | NA | NA | 16 84.2% | 0 | 3² 15.8% | 0 | 19 100% | 0 | 0 | 19 100% |
Total | 22 8.0% | 135 48.9% | 157 56.9% | 48 17.4% | 1 0.4% | 13 4.7% | 31 11.2% | 93 33.7% | 24 8.7% | 2 0.7% | 276 100% |